Eagle Pharmaceuticals Inc (EGRX) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Eagle Pharmaceuticals, Inc. is on the clock to file its overdue quarterly report after receiving a delinquency notice from Nasdaq for not complying with listing rules. They’ve been granted a 180-day extension until May 13, 2024, to submit their financials and avoid delisting. The company’s future on the stock market hangs in the balance as they work to meet the deadline and maintain their listing status.
For further insights into EGRX stock, check out TipRanks’ Stock Analysis page.
